热门资讯> 正文
Amicus Therapeutics 2024财年盈利预览
2025-02-19 03:43
- 爱美医疗(FOLD) 0
- 摩根士丹利(MS) 0
- Amicus Therapeutics (NASDAQ:FOLD) is scheduled to announce FY earnings results on Wednesday, February 19th, before market open.
- The consensus EPS Estimate is $0.24 and the consensus Revenue Estimate is $527.02M.
- Over the last 2 years, FOLD has beaten EPS estimates 63% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 6 upward revisions and 1 downward.
More on Amicus Therapeutics
- Amicus Therapeutics: Cheap Heading Into 2025
- Amicus Therapeutics expects 2024 revenue slightly above consensus, guides 2025
- Morgan Stanley upgrades PTC, cuts Immuneering, Amicus
- Seeking Alpha’s Quant Rating on Amicus Therapeutics
- Historical earnings data for Amicus Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
